ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Several reports documented that BCR-ABL knockdown in the K562 cell line inhibits the notch signaling pathways, and this inhibition shows that notch (1 and 2) have an oncogenic role in CML [2].